GHTM

Global Health and Tropical Medicine

Home / Archives for The Lancet

Global need: including rehabilitation in health system strengthening

CORRESPONDENCE Apropos «Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019» We read with great enthusiasm Alarcos Cieza and colleagues’1 analysis of data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to […]
Read More

Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: A longitudinal study

Background: Yaws is a substantial cause of chronic disfiguring ulcers in children in at least 14 countries in the tropics. WHO’s newly adopted strategy for yaws eradication uses a single round of mass azithromycin treatment followed by targeted treatment programmes, and data from pilot studies have shown a short-term significant reduction of yaws. We assessed […]
Read More

Mosquito control might not bolster imperfect dengue vaccines

The most recent dengue vaccine trial data from Asia claims 40–70% efficacy in children aged 2–14 years. This is a substantial advance in dengue prevention but clearly falls short of the levels of protection required for a standalone intervention. The dengue vaccine initiative and other consortia have emphasised the benefits of integrating vaccines with mosquito control measures, which infers that vector control can bolster the effect of imperfect vaccines.
Read More

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

Map